Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
Related Questions
How would you treat a newly diagnosed hormone sensitive high risk prostate cancer with one small lung metastasis and no other evidence of metastatic disease per PSMA PET?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?
Would you consider re-irradiation in the setting of prior salvage prostatectomy after prostate brachytherapy?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
Do you ever dose escalate radiotherapy to the primary in low volume metastatic prostate cancer?
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?
What are the indications for postoperative radiation for extramammary Paget's disease?
When treating inguinal lymph nodes in the setting of pelvic RT, what is your preferred setup in order to minimize dose to the penis?
